Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-465-8 | CAS number: 12005-21-9
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-12-02 to 2011-01-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Pentaaluminium triyttrium dodecaoxide
- EC Number:
- 234-465-8
- EC Name:
- Pentaaluminium triyttrium dodecaoxide
- Cas Number:
- 12005-21-9
- Molecular formula:
- Al5O12Y3
- IUPAC Name:
- pentaaluminium triyttrium dodecaoxide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): L181
- Substance type: inorganic
- Physical state: solid
- Analytical purity: presumably > 99.9 %
- Lot/batch No.: VS 503G/10
- Expiration date of the lot/batch: not applicable
- Stability under test conditions: stable
- Storage condition of test material: room temperature
- Other:
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Age at study initiation: 9 - 10 weeks
- Weight at study initiation: animals 1 - 3: 158 - 165 g; animals 4 - 6: 176 - 182 g
- Fasting period before study: 16 - 19 h. Access to water was permitted.
- Housing: Full barrier in an air-conditioned room
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: animals 1 - 3: 12 days; animals 4 - 6: 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/3 °C
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: animals 1 - 3: 2010-12-02; animals 4 - 6: 2010-12-09 To: animals 1 - 3: 2011-12-28; animals 4 - 6: 2011-01-04
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- cotton seed oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.4 g/mL
- Amount of vehicle (if gavage): 5 mL
- Justification for choice of vehicle: non-toxic characteristics
- Lot/batch no. (if required): Sigma, lot no. MKBB7604, expiry date 2011-03-01
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg body weight - Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 6
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observation; weighing on days 1 (prior to the administration), 8 and 15
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology, other: no
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality observed
- Clinical signs:
- Prior to the administration a detailed clinical observation was made of all animals.
A careful clinical observation was made several times on the day of dosing; at least once during the first 30 minutes and with special attention during the first 4 hours post-dose. Thereafter, the animals were observed for clinical signs once daily until the end of the observation period.
Clinical signs were not observed during the whole observation period. - Body weight:
- Absolute body weights in g and body weight grain in %
day 1 day 8 day 15 % day 1-15
animal 1 158 172 183 16
animal 2 163 178 191 17
animal 3 165 185 190 15
animal 4 182 193 201 10
animal 5 176 198 203 15
animal 6 177 206 222 25 - Gross pathology:
- With the exception of acute injection of blood vessels in the abdominal region, which is due to the euthanasia injection, no specific gross pathological changes were recorded for any animal.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 value of L181 via the oral route was > 2000 mg/kg body weight.
- Executive summary:
The oral toxicity of L181 was examined in a GLP guideline study according to OECD 423.
Under the conditions of the study, a single oral application to rats at a dose of 2000 mg/kg body weight was associated with no signs of toxicity or mortality.
The median dose level of L181 after a single oral administration to female rats, observed over a period of 14 days is:
LD50 cut-off (rat): unclassified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
